ampelopsin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Cui, M; Gao, D; Li, D; Li, M; Li, X; Lin, J; Ren, S; Ruan, H; Sun, R; Wang, M; Wei, Y; Xiao, T; Yang, C; Zhang, L; Zhou, H | 1 |
1 other study(ies) available for ampelopsin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.
Topics: Animals; Antiviral Agents; Coronavirus 3C Proteases; COVID-19; Fibrosis; Flavonols; Humans; Lung; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2; Virus Replication | 2021 |